1. Abdeahad H, Bahrami A, Saeedi N, Shabani M, Pezeshki M, Khazaei M, et al,. Association between genetic variants at 9p21 locus with risk of breast cancer. Pathol Res Pract 2020;216(7):152987. [
DOI:10.1016/j.prp.2020.152987] [
PMID]
2. Pezeshki M, Ansari J. Evaluating the risk factors of breast Cancer. Paramed Sci Milit Health 2018;13(3):1-11. [
URL]
3. Karimi F, Entezar Mahdi R, Khalkhali HR. Estimation of breast cancer burden in West Azarbaijan province in 2013. Stud Med Sci 2017;28(8):1-7. [
URL]
4. Pezeshki M, Ansari J, Ahmadi A. Investigating the Association between rs712829 Polymorphism of EGFR Gene with Lung Cancer as a Predictive Marker in Iranian Population. Jundishapur Sci Med J 2023;22(4):458-68. [
Google Scholar]
5. Lakzaei M, Salarilak S, Khalkhali HR, Maleki D, Esnaashari O. Association between age of morbidity and prognosis of breast cancer. Stud Med Sci 2015;26(7):625-33. [
Google Scholar]
6. Pezeshki M, Esfandiari M, Tamjidi A, Ahmadi A, Kamijani D. Role of key genes in lung cancer diagnosis and treatment: A review. Paramed Sci Mil Health 2023;18(1):61-77. [
URL]
7. Pezeshki M, Hosseini SM, Ansari J, Ahmadi A. EGFR, Exo1, and LEP gene polymorphisms and lung cancer risk. Egypt J Med Hum Genet 2023;24(1):55. [
DOI:10.1186/s43042-023-00436-8]
8. Karimian N, et al. Increased risk of breast cancer by reducing RHOB gene promoter VNTR repeats. Stud Med Sci 2016;27(8):706-12. [
Google Scholar]
9. Ansari J, Pezeshki M. XRCC3 repair role and risk of breast cancer. Paramed Sci Mil Health 2019;14(4):41-50. [
Google Scholar]
10. Pezeshki M, Ansari J. Study of the association FokI polymorphisms of the XRCC3 gene with the risk of breast cancer in women: brief report. Tehran Univ Med J 2019;76(10):703-7 [
Google Scholar]
11. Hamta A, et al. Pezeshki M, Ansari J. Thr241Met polymorphisms of XRCC3 gene and breast cancer risk in Markazi Province. J Arak Univ Med Sci 2018;20(12):93-103. [
URL]
12. Ali AM, AbdulKareem H, Al Anazi M, Reddy Parine N, Shaik JP, Alamri A, et al. XRCC3 gene polymorphisms and breast cancer susceptibility in Saudi females. BioMed Res Int 2016;2016. [
DOI:10.1155/2016/8721052] [
PMID] [
]
13. Su CH, Chang WS, Hu PS, Hsiao CL, Ji HX, Liao CH, et al. XRCC3 genotypes and triple-negative breast cancer risk. Cancer Genom Proteom 2015;12(6):359-67. [
PMID]
14. Han S, Zhang HT, Wang Z, Xie Y, Tang R, Mao Y, Li Y. XRCC3 polymorphisms and cancer risk: a meta-analysis. Eur J Hum Genet 2006;14(10):1136-44. [
DOI:10.1038/sj.ejhg.5201681] [
PMID]
15. He XF, Wei W, Su J, Yang ZX, Liu Y, Zhang Y, et al. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies. Mol Biol Rep 2012;39(5):5125-34. [
DOI:10.1007/s11033-011-1308-y] [
PMID]
16. Nowacka-Zawisza M, Raszkiewicz A, Kwasiborski T, Forma E, Bryś M, Różański W, et al. RAD51 and XRCC3 polymorphisms and prostate cancer risk. J Oncol 2019;2019. [
DOI:10.1155/2019/2976373] [
PMID] [
]
17. Yuan C, Liu X, Yan S, Wang C, Kong B. XRCC3 gene polymorphism and ovarian cancer risk. BioMed Res Int 2014;2014. [
DOI:10.1155/2014/648137] [
PMID] [
]
18. Sarwar R, Mahjabeen I, Bashir K, Saeed S, Kayani MA. XRCC3 gene polymorphisms and thyroid cancer risk. Cell Physiol Biochem 2017;42(1):22-33. [
DOI:10.1159/000477109] [
PMID]
19. Banegas MP, Bird Y, Moraros J, King S, Prapsiri S, Thompson B. Breast cancer knowledge and early detection in US-Mexico border Latinas. J Women's Health 2012;21(1):101-7. [
DOI:10.1089/jwh.2010.2638] [
PMID] [
]
20. Vral A, Willems P, Claes K, Poppe B, Baeyens A, Perletti G, et al. Polymorphisms in Rad51 and Xrcc3, breast cancer risk, and radiosensitivity. Mol Med Rep 2011;4(5):901-12.
21. Mehrzad J, Dayyani M, Khorasani ME. XRCC3 and XRCC7 polymorphisms and colorectal cancer risk in Khorasan Razavi, Iran. Asian Pac J Cancer Prev 2019;20(7):2153. [
DOI:10.31557/APJCP.2019.20.7.2153] [
PMID] [
]
22. He F, Chang SC, Wallar GM, Zhang ZF, Cai L. XRCC3 and XRCC4 polymorphisms, family history, and lung cancer risk in Chinese population. J Hum Genet 2013;58(10):679-85. [
DOI:10.1038/jhg.2013.78] [
PMID] [
]
23. Tsai CW, Chang WS, Liu JC, Tsai MH, Lin CC, Bau DT. Contribution of DNA double-strand break repair gene XRCC3 genotypes to oral cancer susceptibility in Taiwan. Anticancer Res 2014;34(6):2951-6. [
Google Scholar]